Patents by Inventor Michael P. Zawistoski

Michael P. Zawistoski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
    Publication number: 20230055237
    Abstract: The invention relates to a compound of Formula I, pharmaceutical compositions comprising a compound of Formula I, and pharmaceutically acceptable slats thereof, pharmaceutical compositions comprising such compounds and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula Ito a subject in need thereof.
    Type: Application
    Filed: July 23, 2021
    Publication date: February 23, 2023
    Inventors: Michael P. Zawistoski, Christopher Oalmann, Feng Li, Andrew Kolodziej, Marshall Morningstar
  • Compounds and methods for the treatment of cystic fibrosis
    Patent number: 10072017
    Abstract: The invention relates to a compound of Formula I or IA compositions comprising compounds of Formula I or IA, and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: September 11, 2018
    Assignee: Flatley Discovery Lab, LLC
    Inventors: Michael P. Zawistoski, Asmita Deshpande, Bridget M. Cole
  • Compounds and methods for the treatment of cystic fibrosis
    Patent number: 9944603
    Abstract: The invention relates to a compound of Formula I and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: April 17, 2018
    Assignee: FLATLEY DISCOVERY LAB, LLC
    Inventors: Michael P. Zawistoski, Yevgen Barsukov, Bridget M. Cole, Richard A. Nugent
  • COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
    Publication number: 20170313659
    Abstract: The invention relates to a compound of Formula I and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Application
    Filed: April 10, 2017
    Publication date: November 2, 2017
    Inventors: Michael P. Zawistoski, Yevgen Barsukov, Bridget M. Cole, Richard A. Nugent
  • Compounds and methods for the treatment of cystic fibrosis
    Patent number: 9771327
    Abstract: The invention relates to a compound of Formula I and methods of treating CFTR (cystic fibrosis transmembrane conductance regulator) mediated diseases, in particular cystic fibrosis, comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: September 26, 2017
    Assignee: FLATLEY DISCOVERY LAB, LLC
    Inventors: Michael P. Zawistoski, Yevgen Barsukov, Bridget M. Cole, Richard A. Nugent
  • COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
    Publication number: 20170204110
    Abstract: The invention relates to a compound of Formula I or IA compositions comprising compounds of Formula I or IA, and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Application
    Filed: December 28, 2016
    Publication date: July 20, 2017
    Inventors: Michael P. Zawistoski, Asmita Deshpande, Bridget M. Cole
  • COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
    Publication number: 20140371238
    Abstract: The invention relates to a compound of Formula I and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Application
    Filed: March 13, 2014
    Publication date: December 18, 2014
    Applicant: FLATLEY DISCOVERY LAB
    Inventors: Michael P. Zawistoski, Yevgen Barsukov, Bridget M. Cole, Richard A. Nugent
  • COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
    Publication number: 20140371263
    Abstract: The invention relates to a compound of Formula I and methods of treating CFTR (cystic fibrosis transmembrane conductance regulator) mediated diseases, in particular cystic fibrosis, comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Application
    Filed: March 13, 2014
    Publication date: December 18, 2014
    Applicant: FLATLEY DISCOVERY LAB
    Inventors: Michael P. Zawistoski, Yevgen Barsukov, Bridget M. Cole, Richard A. Nugent
  • Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
    Publication number: 20040192685
    Abstract: This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits comprising such compounds.
    Type: Application
    Filed: April 8, 2004
    Publication date: September 30, 2004
    Inventors: Kimberly O. Cameron, Richard Chesworth, Paul A. DaSilva-Jardine, Robert F. Day, Bruce A. Lefker, Michael P. Zawistoski
  • Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
    Publication number: 20030220494
    Abstract: This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits comprising such compounds.
    Type: Application
    Filed: April 2, 2003
    Publication date: November 27, 2003
    Inventors: Kimberly O. Cameron, Richard Chesworth, Paul A. DaSilva-Jardine, Robert F. Day, Bruce A. Lefker, Michael P. Zawistoski
  • Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
    Patent number: 6608203
    Abstract: This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits comprising such compounds.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: August 19, 2003
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Richard Chesworth, Paul A. DaSilva-Jardine, Robert F. Day, Bruce A. Lefker, Michael P. Zawistoski
  • Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
    Publication number: 20010039285
    Abstract: This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits comprising such compounds.
    Type: Application
    Filed: December 21, 2000
    Publication date: November 8, 2001
    Inventors: Kimberly O. Cameron, Richard Chesworth, Paul A. DaSilva-Jardine, Robert F. Day, Bruce A. Lefker, Michael P. Zawistoski